Saikosaponin B2

HCID 21637642

기본 정보

CAS
58316-41-9
표준 SMILES
C[C@H]1O[C@@H](O[C@H]2CC[C@@]3(C)[C@@H](CC[C@]4(C)[C@@H]3C=CC3=C5CC(C)(C)CC[C@]5(CO)[C@H](O)C[C@]34C)[C@]2(C)CO)[C@H](O)[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H]1O
InChIKey
WRYJYFCCMSVEPQ-ORAXXRKOSA-N
분자식
C42H68O13
평균 분자량
781 g/mol
단동위원소 질량
780.46599222

개요

Saikosaponin b2 is a saikosaponin.

이름 및 식별자

우선 이름
Saikosaponin B2
IUPAC
(2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-2-[[(3S,4R,4aR,6aR,6bS,8R,8aS,14aR,14bS)-8-hydroxy-4,8a-bis(hydroxymethyl)-4,6a,6b,11,11,14b-hexamethyl-1,2,3,4a,5,6,7,8,9,10,12,14a-dodecahydropicen-3-yl]oxy]-3,5-dihydroxy-6-methyloxan-4-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
영어명
Saikosaponin B2
분자식
C42H68O13
분자량
780.99

이름 및 동의어

Saikosaponin B258316-41-9DTXSID40670024RefChem:180858DTXCID901838996bupleurum saponin B2Saikosaponin B2 (Standard)(2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-2-[[(3S,4R,4aR,6aR,6bS,8R,8aS,14aR,14bS)-8-hydroxy-4,8a-bis(hydroxymethyl)-4,6a,6b,11,11,14b-hexamethyl-1,2,3,4a,5,6,7,8,9,10,12,14a-dodecahydropicen-3-yl]oxy]-3,5-dihydroxy-6-methyloxan-4-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triolorb1222010orb1303719orb3139552SCHEMBL7523565
이름 더 보기
Saikosaponin BIISaikosaponin B2-RMFluoro nitroanilineSAIKOSAPONIN B2(RG)Saikosaponin b2 std.SAIKOSAPONINB2STANDARDβ-D- fucoside, (3β,4α,16α) -16,23,28-Saikosaponin B2, 98%, from Bupleurum chinense DC.trihydroxyoleana-11,13(18)-dien-3-yl6-deoxy-3-O-β-D-glucopyranosyl-
CHEMBL3792981HY-N0248RCHEBI:183954HY-N0248AKOS037514824CCG-270463EBC-616621OS09507

데이터베이스 식별자

CAS
58316-41-9
PubChem CID
21637642
DTXSID
DTXSID40670024
ChEMBL
CHEMBL3792981
ChEBI
CHEBI:183954
Nikkaji
J246.209E

물성

구조 계산 물성

XLogP
2.5
극성 표면적
219 Ų
수소 결합 공여자 수
9
수소 결합 수용자 수
13
회전 가능 결합 수
7
무거운 원자 수
55

물리화학적 성질

녹는점
231 · 231-238°C
끓는 점
909.9 · 909.9±65.0 °C(Predicted)
밀도
1.35 · 1.35±0.1 g/cm3(Predicted)
저장 조건
2 · 2-8°C
용해도
Soluble in methanol;
물리적 상태
가루

안전 및 규제

안전 데이터

wgk
WGK 3
스토리지 클래스
11 - Combustible Solids

화학 및 산업

약리 정보

MeSH Pharmacological Classification · 4건

Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects.

Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity.

Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly.

Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging.

공급사100 곳

北京华美互利生物化工010-56205725 · [email protected]
成都普瑞法科技开发有限公司+86-028-82633397 18982077548 · [email protected]
成都曼思特生物科技有限公司18010516991 · [email protected]
济南百隆化学有限公司[email protected] · [email protected]
南京普怡生物科技有限公司13814510036 · [email protected]

관련 반응

1건

화합물 노트

불러오는 중…